These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18570935)

  • 1. eIF4E-targeted suicide gene therapy in a minimal residual mouse model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free survival.
    Siegele B; Cefalu C; Holm N; Sun G; Tubbs J; Meschonat C; Odaka Y; DeBenedetti A; Ghali GE; Chu Q; Mathis JM; Li BD
    J Surg Res; 2008 Jul; 148(1):83-9. PubMed ID: 18570935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.
    Mathis JM; Williams BJ; Sibley DA; Carroll JL; Li J; Odaka Y; Barlow S; Nathan CO; Li BD; DeBenedetti A
    J Gene Med; 2006 Sep; 8(9):1105-20. PubMed ID: 16802401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel suicide gene therapy targeting the overexpression of eukaryotic initiation factor 4E improves survival in a rat peritoneal carcinomatosis model.
    Byrnes K; Li BD; Holm N; Li J; Okadata Y; De Benedetti A; Nedeljkovic-Kurepa A; Mathis M; Chu QD
    Surgery; 2007 Aug; 142(2):270-5. PubMed ID: 17689695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat adenocarcinoma cell line infected with an adenovirus carrying a novel herpes-simplex virus-thymidine kinase suicide gene construct dies by apoptosis upon treatment with ganciclovir.
    Chu QD; Sun L; Li J; Byrnes K; Chervenak D; DeBenedetti A; Mathis JM; Li BD
    J Surg Res; 2007 Nov; 143(1):189-94. PubMed ID: 17950092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
    Morris JC; Wildner O
    Mol Ther; 2000 Jan; 1(1):56-62. PubMed ID: 10933912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity and antiangiogenesis by fibroblast growth factor 2-targeted Ad-TK cancer gene therapy.
    Saito K; Khan K; Sosnowski B; Li D; O'Malley BW
    Laryngoscope; 2009 Apr; 119(4):665-74. PubMed ID: 19213040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined interleukin-2 and herpes simplex virus thymidine kinase gene therapy for head and neck squamous cell carcinoma].
    Liu S; Liang C; Yang H; Xian J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):426-9. PubMed ID: 12761956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer.
    Day KV; Li D; Liu S; Guo M; O'Malley BW
    Laryngoscope; 2001 May; 111(5):801-6. PubMed ID: 11368071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
    Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
    Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study on lung carcinoma-targeted suicide gene therapy induced by irradiation].
    Wang WD; Chen ZT; Li DZ; Duan YZ; Cao ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):84-7. PubMed ID: 12783658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
    Kuriyama N; Kuriyama H; Julin CM; Lamborn KR; Israel MA
    Cancer Res; 2001 Mar; 61(5):1805-9. PubMed ID: 11280727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cancer gene therapy approach through translational control of a suicide gene.
    DeFatta RJ; Chervenak RP; De Benedetti A
    Cancer Gene Ther; 2002 Jun; 9(6):505-12. PubMed ID: 12032661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model.
    O'Malley BW; Chen SH; Schwartz MR; Woo SL
    Cancer Res; 1995 Mar; 55(5):1080-5. PubMed ID: 7866992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
    Janousková O; Síma P; Kunke D
    Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
    Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
    Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
    Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
    J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
    Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.